M. Jason Hatfield

1.9k total citations
27 papers, 1.4k citations indexed

About

M. Jason Hatfield is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, M. Jason Hatfield has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pharmacology and 7 papers in Computational Theory and Mathematics. Recurrent topics in M. Jason Hatfield's work include Cholinesterase and Neurodegenerative Diseases (12 papers), Computational Drug Discovery Methods (7 papers) and Enzyme function and inhibition (4 papers). M. Jason Hatfield is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (12 papers), Computational Drug Discovery Methods (7 papers) and Enzyme function and inhibition (4 papers). M. Jason Hatfield collaborates with scholars based in United States, Bangladesh and South Korea. M. Jason Hatfield's co-authors include Philip M. Potter, Carol C. Edwards, Janice L. Hyatt, Lyudmila Tsurkan, E. Galanis, David H. Kirn, James L. Abbruzzese, Joseph Rubin, Monika Wierdl and Abdolsamad Borazjani and has published in prestigious journals such as Radiology, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

M. Jason Hatfield

27 papers receiving 1.3k citations

Peers

M. Jason Hatfield

GENET

PHARM

ONCOL

Benjamin J. Orlando United States

Isaac M. Westwood United Kingdom

Janice L. Hyatt United States

J M Trzaskos United States

Midori A. Arai Japan

Qingzhi Gao China

S. Nanjunda Swamy India

Mary Erman United States

Michael Brands Germany

Benjamin J. Orlando United States

M. Jason Hatfield

801 ×1.3

146 ×0.3

GENET

322 ×0.9

PHARM

230 ×0.7

ONCOL

322 ×1.6

Citations per year, relative to M. Jason Hatfield M. Jason Hatfield (= 1×) peers Benjamin J. Orlando

Countries citing papers authored by M. Jason Hatfield

Since Specialization

Citations

This map shows the geographic impact of M. Jason Hatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jason Hatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jason Hatfield more than expected).

Fields of papers citing papers by M. Jason Hatfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jason Hatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jason Hatfield. The network helps show where M. Jason Hatfield may publish in the future.

Co-authorship network of co-authors of M. Jason Hatfield

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jason Hatfield. A scholar is included among the top collaborators of M. Jason Hatfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jason Hatfield. M. Jason Hatfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Yao, et al.. (2024). Cold exposure impacts DNA methylation patterns in cattle sperm. Frontiers in Genetics. 15. 1346150–1346150. 1 indexed citations

Hatfield, M. Jason, et al.. (2018). Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors. European Journal of Medicinal Chemistry. 149. 79–89. 21 indexed citations

Wierdl, Monika, Lyudmila Tsurkan, Liying Chi, et al.. (2018). Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemotherapy and Pharmacology. 82(2). 251–263. 7 indexed citations

Hatfield, M. Jason, et al.. (2018). Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza (“Danshen”). Journal of Natural Products. 81(11). 2410–2418. 15 indexed citations

Hatfield, M. Jason, Jingwen Chen, Liying Chi, et al.. (2017). Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction Profiling. Journal of Medicinal Chemistry. 60(4). 1568–1579. 33 indexed citations

Wierdl, Monika, Lyudmila Tsurkan, M. Jason Hatfield, & Philip M. Potter. (2016). Tumour‐selective targeting of drug metabolizing enzymes to treat metastatic cancer. British Journal of Pharmacology. 173(19). 2811–2818. 4 indexed citations

Hatfield, M. Jason, Robyn A. Umans, Janice L. Hyatt, et al.. (2016). Carboxylesterases: General detoxifying enzymes. Chemico-Biological Interactions. 259(Pt B). 327–331. 129 indexed citations

Hatfield, M. Jason, Lyudmila Tsurkan, Janice L. Hyatt, et al.. (2013). Modulation of Esterified Drug Metabolism by Tanshinones from Salvia miltiorrhiza (“Danshen”). Journal of Natural Products. 76(1). 36–44. 56 indexed citations

Tsurkan, Lyudmila, M. Jason Hatfield, Carol C. Edwards, Janice L. Hyatt, & Philip M. Potter. (2012). Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors. Chemico-Biological Interactions. 203(1). 226–230. 48 indexed citations

10.

Hatfield, M. Jason & Philip M. Potter. (2011). Carboxylesterase inhibitors. Expert Opinion on Therapeutic Patents. 21(8). 1159–1171. 103 indexed citations

11.

Parkinson, Elizabeth I., M. Jason Hatfield, Lyudmila Tsurkan, et al.. (2011). Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones. Bioorganic & Medicinal Chemistry. 19(15). 4635–4643. 20 indexed citations

12.

Hatfield, M. Jason, Lyudmila Tsurkan, Michael R. Garrett, et al.. (2010). Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11. Biochemical Pharmacology. 81(1). 24–31. 75 indexed citations

13.

Crow, J. Allen, et al.. (2008). Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1781(10). 643–654. 68 indexed citations

14.

Wierdl, Monika, Lyudmila Tsurkan, Janice L. Hyatt, et al.. (2008). An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11. Cancer Gene Therapy. 15(3). 183–192. 43 indexed citations

15.

Hwang, Tae-Ho, Hyuk-Chan Kwon, Kelly Speth, et al.. (2007). A phase I-II clinical trial with JX-594, a targeted and GM-CSF-armed oncolytic poxvirus, by intratumoral injection in patients with liver tumors. Molecular Cancer Therapeutics. 6. 5 indexed citations

16.

Hyatt, Janice L., Randy M. Wadkins, Lyudmila Tsurkan, et al.. (2007). Planarity and Constraint of the Carbonyl Groups in 1,2-Diones Are Determinants for Selective Inhibition of Human Carboxylesterase 1. Journal of Medicinal Chemistry. 50(23). 5727–5734. 34 indexed citations

17.

Hyatt, Janice L., M. Jason Hatfield, Lyudmila Tsurkan, et al.. (2007). Selective Inhibition of Carboxylesterases by Isatins, Indole-2,3-diones. Journal of Medicinal Chemistry. 50(8). 1876–1885. 60 indexed citations

18.

Hatfield, M. Jason, et al.. (2006). Low-molecular-weight chromium-binding substance from chicken liver and American alligator liver. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 144(4). 423–431. 10 indexed citations

19.

Yoon, Karina J., Jianjun Qi, Joanna S. Remack, et al.. (2006). Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy. Molecular Cancer Therapeutics. 5(6). 1577–1584. 4 indexed citations

20.

Reid, T., E. Galanis, James L. Abbruzzese, et al.. (2001). Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Therapy. 8(21). 1618–1626. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact